Emtriva

Active Ingredient(s): Emtricitabine
FDA Approved: * July 2, 2003
Pharm Company: * GILEAD
Category: HIV / AIDS

Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. Emtricitabine is also marketed in a fixed-dose combination with tenofovir disoproxil (Viread) under the brand name Truvada, and with tenofovir alafenamide (Vemlidy) under the brand name Descovy. A fixed-dose tr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Emtriva 200mg;GILEAD
Emtriva 200 mg Oral Capsule
NDC: 61958-0601
Labeler:
Gilead Sciences, Inc.
Emtriva 200mg;GILEAD
Emtriva 200 mg Oral Capsule
NDC: 24236-297
Labeler:
Remedyrepack Inc.
Emtriva 200mg;GILEAD
Emtriva 200 mg Oral Capsule
NDC: 70518-1847
Labeler:
Remedyrepack Inc.
Emtriva 200 mg Oral Capsule
NDC: 46014-0601
Labeler:
Excella Gmbh
Emtriva 200 mg Oral Capsule
NDC: 53808-0801
Labeler:
State of Florida Doh Central Pharmacy
Emtriva 200 mg Oral Capsule
NDC: 54868-4853
Labeler:
Physicians Total Care, Inc.
Emtriva 10 mg/ml Oral Solution
NDC: 61958-0602
Labeler:
Gilead Sciences, Inc.